First Western Trust Bank Dexcom Inc Transaction History

First Western Trust Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$75.49 - $124.16 $131,503 - $216,286	1,742 New	1,742 $216,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $14,560 - $17,208	-140 Reduced 7.2%	1,804 $209,000
Q4 2022 Feb 10, 2023	BUY	$84.98 - $122.67 $165,201 - $238,470	1,944 New	1,944 $220,000
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $43,513 - $85,049	-640 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $60,211 - $83,328	640 New	640 $332,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of First Western Trust Bank, based on Form 13F filings with the SEC.

Stay updated on First Western Trust Bank with notifications on news.